U.S., Feb. 5 -- ClinicalTrials.gov registry received information related to the study (NCT06241183) titled 'Famotidine and Antacids for Treatment of Dyspepsia' on Jan. 16.
Brief Summary: The aim of this study is to compare intravenous famotidine, an H2 receptor antagonist, and Maalox/ Mylanta, an oral antacid, in treatment of dyspepsia in the emergency department. The goal of this study is to reduce patients' pain based on the verbal numerical pain scale. The anticipated outcome is for pain levels in both groups to decrease. It is expected that antacids will improve symptoms more quickly and to a greater degree within an hour of taking medication based on the results of similar studies.
Study Type: Interventional
Condition: * Dyspepsia
...